Sabra Health Care

Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Sabra Health Care reports strong Q4 performance amidst Enlivant JV challenges

Sabra Health Care showcased improved performance in occupancy rates and revenue growth, with a strategic focus on senior housing opportunities.
Despite challenges from the Enlivant JV impact and market uncertainties, Sabra's strengths in debt management and asset operations position it well for future growth.
Opportunities lie in securing interest rates, expanding in the senior housing sector, and resolving uncertainties around the Enlivant JV for strategic advancement.
Addressing challenges such as transaction market dynamics and maintaining growth momentum will be crucial for Sabra's continued success in the healthcare real estate sector.

Sabra Health Care reports stable Q1 performance amidst market challenges

Sabra Health Care's Q1 2023 performance reflects stability and operational improvements in skilled nursing and senior housing portfolios.
While facing challenges in investment activity and rising debt financing rates, the company is leveraging opportunities in Medicaid rate increases and strategic investments.
Maintaining financial strength and flexibility, Sabra Health Care is poised to navigate market uncertainties and drive operational efficiency.

Sabra Health Care reports robust Q2 performance and eyes 2024 growth

Sabra Health Care's Q2 2023 earnings call highlighted positive performance metrics, ongoing margin recovery efforts, and strategic initiatives to drive occupancy and revenue growth. Despite challenges in the IL segment and market dynamics, the company's strong financial position and focus on portfolio optimization position it well for future opportunities.

Sabra Health Care posts robust Q3 results, eyes growth opportunities

Sabra Health Care's Q3 2023 earnings call reflects strong performance, portfolio stability, and growth potential. Challenges include maintaining coverage ratios and addressing analyst concerns. Opportunities exist in acquisitions, financing, and leveraging portfolio momentum.

Sabra Health Care reports strong Q4 performance and eyes industry growth opportunities

Sabra Health Care showcased strong performance in occupancy and financial metrics, with a focus on operational improvements and growth strategies.
While facing challenges related to occupancy levels and construction costs, the company remains optimistic about industry recovery and growth potential.
Opportunities in the skilled nursing space and sale-leaseback investments present avenues for expansion and strategic development.
Analysts' inquiries and discussions on acquisitions, regulatory issues, and financial guidance reflect a dynamic landscape with potential for strategic advancements.

Sabra Health Care reports solid Q3 performance amidst cautious outlook

Sabra Health Care's Q3 2024 earnings call reflected strong financial performance, strategic focus on quality investments, and cautious outlook on guidance and debt metrics. The company faces competition in skilled nursing but sees opportunities in acquisitions and margin improvement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Sabra (SBRA) Q1 Earnings: A Look at Key Metrics

TUSTIN, Calif.--(BUSINESS WIRE)-- #1Q24--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2024. FIRST QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2024 were as follows: Net Income: $0.11 FFO: $0.32 Normalized FFO: $0.34 AFFO: $0.35 Normalized AFFO: $0.35 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.79x (1.79x excluding Provider Relief Fund.

Sabra Reports First Quarter 2024 Results; Reiterates 2024 Guidance

Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS

TUSTIN, Calif.--(BUSINESS WIRE)-- #1Q24--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2024 first quarter earnings release on May 8, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2024 first quarter results will be held on Thursday, May 9 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number i.

Sabra Health Care REIT, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call

TUSTIN, Calif.--(BUSINESS WIRE)-- #DeutscheBank--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, and Darrin Smith, the company's Executive Vice President of Investments, will attend the Deutsche Bank Inaugural Healthcare REIT Summit virtually on April 2, 2024. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat.

Sabra Health Care REIT, Inc. to Attend the Deutsche Bank Inaugural Healthcare REIT Summit

Generating steady income from rentals and a historical resilience in the face of economic adversities make real investment trusts (REITs) a viable choice for growth investors and those hedging against inflation. While residential REITs may be the most familiar type of REITs, medical and healthcare REITs can also be one of the most profitable additions to your investment portfolio.

Healthcare havens: The medical REIT with a pulse on the future

Best Buy

Kohl's

Pfizer

AT&T

TC Energy

The company offers medicines and vaccines in various therapeutic areas, including: Cardiovascular metabolic and women's health under the Premarin family and Eliquis brands Biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands Sterile injectable and anti-infective medicines and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands.

6 Bargain Dividend Stocks To Buy

Sabra Health Care REIT, Inc. (SBRA) Q4 2023 Earnings Call Transcript

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.33 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to FFO of $0.37 per share a year ago.

Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates

TUSTIN, Calif.--(BUSINESS WIRE)-- #4Q23--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2023. FOURTH QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2023 were as follows: Net Income: $0.07 FFO: $0.30 Normalized FFO: $0.32 AFFO: $0.32 Normalized AFFO: $0.33 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.78x (1.72x excluding Provider Relief F.

Sabra Reports Fourth Quarter 2023 Results; Introduces 2024 Guidance

Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Anheuser-Busch InBev

Energy Transfer LP Unit

Altria

MPLX

Sunoco

USA Compression Partners

Western Union

Sponsored: Find a Qualified Financial Advisor Finding a qualified financial advisor doesn't have to be hard.

7 Blue-Chip Bargains With 7% and Higher Dividends

TUSTIN, Calif.--(BUSINESS WIRE)-- #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Citi's 2024 Global Property CEO Conference on March 4-6, 2024, at The Diplomat Beach Resort in Hollywood, Florida. Additionally, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, th.

Sabra Health Care REIT, Inc. to Attend Citi's 2024 Global Property CEO Conference and the 2024 NIC Spring Conference

Sabra Health Care REIT has strong upside potential with a diverse and stable portfolio, high occupancy rates, and a history of consistent dividend payments. The company is well-positioned to benefit from tailwinds, such as the aging population and rising healthcare spending. However, investors should be aware of headwinds, including regulatory uncertainty and high leverage, as well as the potential for near-term volatility with the upcoming Q4 2023 earnings announcement.

Sabra Health Care REIT: A Risk Worth Taking

IRVINE, Calif.--(BUSINESS WIRE)-- #4Q23--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2023 fourth quarter earnings release on February 27, 2024, after the close of trading. A conference call with a simultaneous webcast to discuss the 2023 fourth quarter results will be held on Wednesday, February 28 at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-596-4144. For participants outside the U.S., the dial-in number is 646-968-2525. The confere.

Sabra Health Care REIT, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call; Declares Common Dividend

IRVINE, Calif.--(BUSINESS WIRE)-- #2023Dividends--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2023 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share   Total Ordinary Dividends   Non- Qualified Dividends   Qualified Dividends   Non- Dividend Distributions 02/13/2023 02/28/2023 $ 0.3000000   $ 0.1709313.

Sabra Health Care REIT, Inc. Announces Tax Treatment of 2023 Distributions

IRVINE, Calif.--(BUSINESS WIRE)-- #CAO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held.

Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

IRVINE, Calif.--(BUSINESS WIRE)-- #Stifel--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, and Lukas Hartwich, the company's Senior Vice President of Finance, will participate virtually in Stifel's 2024 Seniors Housing and Healthcare Real Estate Conference on January 9, 2024. About Sabra Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. to Participate in the Stifel 2024 Seniors Housing and Healthcare Real Estate Conference

Alexandria Real Estate Equities

Brixmor Property Group

Boston Properties

Centerspace REIT

CTO Realty Growth

Equity LifeStyle Properties

Equity Residential

Extra Space Storage

Highwoods Properties

Healthcare Realty Trust Inc

Invitation Homes

Independence Realty Trust

InvenTrust Properties Corp

Mid-America Apartment Communities

National Storage Affiliates Trust

Phillips Edison & Co Inc

Public Storage

Rexford Industrial Realty

SITE Centers Corp

Tanger Factory Outlet Centers

Simon Property Group

Sun Communities

Ventas

REITWorld conference in Los Angeles featured 29 meetings, including exclusive sessions with REIT CEOs and CFOs, and property tours. Common themes discussed included cautious optimism on 2024 fundamentals, distressed opportunities, and challenges in the market. Actionable ideas and key takeaways were gathered from the meetings, covering various sectors such as shopping centers, healthcare, multifamily, self-storage, industrial, office, and life science.

Property Type Round-Up From REITWorld

Apartment Income REIT Corp

BRT Apartments

CBL & Associates Properties

Crown Castle International

Clipper Realty

CIM Commercial Trust

Dominion Energy

Easterly Government Properties

Generation Income Properties

Global Medical REIT

Global Net Lease

Gladstone Commercial

Modiv

Omega Healthcare Investors

One Liberty Properties

OUTFRONT Media

Postal Realty Trust

Presidio Property Trust

Service Properties Trust

UMH Properties

Overall, this is a good time to invest in REITs. The expected surge in REIT share prices will not benefit all REITs equally. There are always mousetrap REITs, even in the best of times. Dividend safety is crucial for REIT value as a dividend cut can lead to a significant loss in share value.

Mouse Traps: 8 High-Yielding REITs Risking Dividend Cuts

Sabra Healthcare has risen since our last piece and has outperformed the broader indices. The senior housing and skilled nursing sectors are showing signs of improvement and SBRA's numbers are filled with green shoots. 2024 should see some growth after multiple years of declines, but we still think there is a better choice over this 8.22% yielding REIT.

Sabra Health Care REIT: Setup For Growth In 2024, But We Prefer Another REIT

AstraZeneca

COPT Defense Properties

Gilead Sciences

Gaming and Leisure Properties

Host Hotels & Resorts

Johnson Controls

LTC Properties

Merck

Banco Santander

Telia Co AB

V.F.

Vici Properties

Telefonica Brasil

September-October, 2023, Barron's, Bloomberg, and Fortune analysts and reporters combined to list five sets of stocks sorted as “Recovery Bets.” Those five articles revealed 53 equities, with 42 paying-dividends. These recovery lists focus on financial services, healthcare, and real estate sectors by Barron's along with selected “change the world” stocks from Fortune and ten to watch from Bloomberg.

17 Ideal Pre-Crash Recovery December Divi-Dogs

Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2023 Earnings Conference Call November 7, 2023 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President and Chairman Talya Nevo-Hacohen - Chief Investment Officer, Treasurer and Executive Vice President Michael Costa - Chief Financial Officer, Secretary and Executive Vice President Conference Call Participants Joshua Dennerlein - Bank of America Juan Sanabria - BMO Capital Markets Rich Anderson - Wedbush Wes Golladay - Baird Michael Griffin - Citi John Pawlowski - Green Street Operator Good day, everyone. My name is Briana and I will be your conference operator today.

Sabra Health Care REIT, Inc. (SBRA) Q3 2023 Earnings Call Transcript

IRVINE, Calif.--(BUSINESS WIRE)-- #3Q23--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2023. THIRD QUARTER 2023 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2023 were as follows: Net Loss: $(0.07) FFO: $0.33 Normalized FFO: $0.33 AFFO: $0.35 Normalized AFFO: $0.34 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 1.68x (1.61x excluding Provider Relief Fund.

Sabra Reports Third Quarter 2023 Results

News for Sabra Health Care Stock (SBRA)